Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2014, Article ID 682583, 6 pages
http://dx.doi.org/10.1155/2014/682583
Case Report

Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report

1Ophthalmiatrion Athinon, 26 Eleftheriou Venizelou Street, 10672 Athens, Greece
2Eye CU Center, 8 Naiadon Street, 11634 Athens, Greece
31st Department of Ophthalmology, University of Athens, G. Gennimatas Hospital, 154 Mesogeion Street, 11527 Athens, Greece

Received 26 September 2014; Accepted 14 November 2014; Published 23 November 2014

Academic Editor: Maurizio Battaglia Parodi

Copyright © 2014 Panagiotis G. Mitropoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Panagiotis G. Mitropoulos, Irini P. Chatziralli, Efstratios A. Parikakis, Vasileios G. Peponis, Georgios A. Amariotakis, and Marilita M. Moschos, “Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report,” Case Reports in Ophthalmological Medicine, vol. 2014, Article ID 682583, 6 pages, 2014. https://doi.org/10.1155/2014/682583.